IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients
An open, single-center, randomized controlled phase II clinical trial to compare the efficacy and safety of conformal intensity modulated radiation therapy (IMRT) combined with carboplatin and IMRT combined with carboplatin and 5-FU in elderly patients with locally advanced esophageal squamous cell carcinoma at high risk of chemotherapy
Esophageal Cancer|Radiotherapy Side Effect
DRUG: Fluorouracil|RADIATION: Intensity modulated radiation therapy|DRUG: carboplatin
Overall objective response rate, The proportion of partial and complete remission of tumors, up to 24 months
Incidence of toxic and side effects above 3 degrees, The Incidence of toxic and side effects above 3 degrees in overall patients, up to 24 months
Esophageal cancer is one of the most common malignant tumors in China.To compare the efficacy and safety of conformal intensity modulated radiation therapy (IMRT) combined with carboplatin and IMRT combined with carboplatin and 5-FU in elderly patients with locally advanced esophageal squamous cell carcinoma at high risk of chemotherapy.This trial is an open, single-center, randomized controlled phase II clinical trial.